Cell Biotech (Korea) Today
| 049960 Stock | KRW 12,920 80.00 0.62% |
PerformanceVery Weak
| Odds Of DistressLow
|
Cell Biotech is trading at 12920.00 as of the 21st of March 2025, a 0.62 percent decrease since the beginning of the trading day. The stock's open price was 13000.0. Cell Biotech has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 21st of December 2024 and ending today, the 21st of March 2025. Click here to learn more.
Cell Biotech Co., Ltd., a biotechnology company, develops and sells lactic acid bacteria in South Korea. Cell Biotech Co., Ltd. was founded in 1995 and is based in Gimpo, South Korea. CBT is traded on Korean Securities Dealers Automated Quotations in South Korea. The company has 7.72 M outstanding shares. More on Cell Biotech Co
Moving against Cell Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Cell Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Cell Biotech's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Cell Biotech or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Health Care, Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care (View all Sectors) |
Cell Biotech Co (049960) is traded on KOSDAQ in Korea and employs 115 people. The company currently falls under 'Mega-Cap' category with a current market capitalization of 109.24 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Cell Biotech's market, we take the total number of its shares issued and multiply it by Cell Biotech's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Cell Biotech operates under Biotechnology sector and is part of Health Care industry. The entity has 7.72 M outstanding shares.
Cell Biotech Co has accumulated about 9.85 B in cash with 14.89 B of positive cash flow from operations.
Check Cell Biotech Probability Of Bankruptcy
Ownership AllocationThe market capitalization of Cell Biotech is W109.24 Billion. Cell Biotech Co retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please take into account that even companies with profitable outlook can generate negative future returns on their equity. If the true value of the firm is less than the current market value, you may not be able generate positive returns on investment in the long run.
Check Cell Ownership Details
Cell Biotech Risk Profiles
Although Cell Biotech's alpha and beta are two of the key measurements used to evaluate Cell Biotech's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 0.9368 | |||
| Standard Deviation | 1.31 | |||
| Variance | 1.71 | |||
| Risk Adjusted Performance | (0.01) |
Cell Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Cell Biotech without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Aroon Oscillator Now
Aroon OscillatorAnalyze current equity momentum using Aroon Oscillator and other momentum ratios |
| All Next | Launch Module |
Other Information on Investing in Cell Stock
Cell Biotech financial ratios help investors to determine whether Cell Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cell with respect to the benefits of owning Cell Biotech security.